Skip to main
MDT

Medtronic (MDT) Stock Forecast & Price Target

Medtronic (MDT) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 17%
Buy 44%
Hold 39%
Sell 0%
Strong Sell 0%

Bulls say

Medtronic is a leading medical device company with a strong portfolio of products targeted towards chronic diseases. With a large portion of sales coming from international markets and strong financials, including revenue growth of 5-7% and operating margin improvement, we believe the company is well-positioned for future success. Furthermore, recent acquisitions such as Scientia Vascular and CathWorks demonstrate Medtronic's commitment to pursuing strategic opportunities for growth and innovation.

Bears say

Medtronic is facing numerous challenges due to unsuccessful new product launches, loss of market share in certain product categories, and declining operating margins, leading to below-consensus earnings. Additionally, their recent acquisition of Scientia Vascular may not provide the desired boost to their portfolio, and their recent earnings beat was driven by currency tailwinds rather than underlying growth. However, there are potential upside drivers, such as stronger sales of new products and improved margins, which could improve the company's outlook.

Medtronic (MDT) has been analyzed by 18 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 44% recommend Buy, 39% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medtronic (MDT) Forecast

Analysts have given Medtronic (MDT) a Buy based on their latest research and market trends.

According to 18 analysts, Medtronic (MDT) has a Buy consensus rating as of May 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $108.56, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $108.56, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medtronic (MDT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.